Structure Therapeutics (GPCR) Other Working Capital Changes (2022 - 2026)
Structure Therapeutics (GPCR) posted quarterly Other Working Capital Changes of $206000.0 for Q1 2026, up 144.88% year-over-year from $84122.8 in Q1 2025, and up 134.16% quarter-over-quarter from -$603000.0 in Q4 2025.
Structure Therapeutics (GPCR) Other Working Capital Changes (2022 - 2026) Analysis & Trends
Structure Therapeutics' Other Working Capital Changes history runs 5 years deep, the most recent figure standing at $206000.0 for Q1 2026.
- In Q1 2026, Other Working Capital Changes rose 144.88% year-over-year to $206000.0; the TTM figure through Mar 2026 stood at -$1.6 million (up 5.28% YoY), while the FY2025 annual figure was -$2.3 million, down 44.31% from the prior year.
- Other Working Capital Changes for Q1 2026 stood at $206000.0, up from -$603000.0 in the prior quarter.
- The five-year high for Other Working Capital Changes was $9.1 million in Q4 2025, with the low at -$2.4 million in Q2 2024.
- The 5-year median for Other Working Capital Changes is $893000.0 (2022), against an average of $1.8 million.
- The sharpest annual moves came in 2024 and 2026: Other Working Capital Changes tumbled 636.62% in 2024, then jumped 144.88% in 2026.
- Structure Therapeutics' Other Working Capital Changes stood at -$84000.0 in 2022, then rose by 15.48% to -$71000.0 in 2023, then sank by 636.62% to -$523000.0 in 2024, then decreased by 15.3% to -$603000.0 in 2025, then soared by 134.16% to $206000.0 in 2026.
- Business Quant data shows GPCR's Other Working Capital Changes at $206000.0 in Q1 2026, -$603000.0 in Q4 2025, and -$601000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn |
| 10 | Structure Therapeutics | 11.65 Bn | 11.65 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -763,000.00 |
| Jun 30, 2026 | -763,000.00 |
| Jun 30, 2026 | -763,000.00 |
| Mar 31, 2026 | 206,000.00 |
| Mar 31, 2026 | 206,000.00 |
| Mar 31, 2026 | 206,000.00 |
| Dec 31, 2025 | -603,000.00 |
| Dec 31, 2025 | -603,000.00 |
| Dec 31, 2025 | -603,000.00 |
| Sep 30, 2025 | -601,000.00 |
| Sep 30, 2025 | -601,000.00 |
| Sep 30, 2025 | -601,000.00 |
| Jun 30, 2025 | -633,000.00 |
| Jun 30, 2025 | -633,000.00 |
| Jun 30, 2025 | -633,000.00 |
| Mar 31, 2025 | -459,000.00 |
| Mar 31, 2025 | -459,000.00 |
| Mar 31, 2025 | -459,000.00 |
| Dec 31, 2024 | -523,000.00 |
| Dec 31, 2024 | -523,000.00 |